YTEN - Yield10 Bioscience shares rise after Q4 results

Yield10 Bioscience (YTEN) shares rise more than 10% during post market trading after the company posted a 43% jump in fourth quarter revenue.The company posted Q4 revenue of $0.2M, an increase of 43% from last year, but missed analysts' average estimate by $0.05M.Yield10 said that its present capital resources, including funds received in early 2021, are expected to fund the company's planned operations into Q1 of 2023.The company reported a net loss after taxes of $10.2M, or $4.30/share for the year ended December 31, 2020 compare to a net loss after taxes of $13M, or $35.50/share last year.Yield10 ended 2020 with $9.7M in unrestricted cash, cash equivalents and short-term investments. It expects net cash usage during 2021 in a range of about $10M- $11M.Previously (March 16): Yield10 Bioscience EPS misses by $0.09, misses on revenue.

For further details see:

Yield10 Bioscience shares rise after Q4 results